-Universitätsklinikder

85
comparison of multimarker molecular and immunopathological methods.
Melanoma Research 13, 511–520
Robert Koch Institut. Malignes Melanom der Haut (2012) (Zugriff vom
28.04.2014).
http://www.rki.de/Krebs/DE/Content/Krebsarten/Melanom/melanom_inhalt.ht
ml
Santamaria-Kisiel, L., Rintala-Dempsey, A. C. and Shaw, G. S. (2006).
Calcium-dependent and -independent interactions of the S100 protein family.
The Biochemical Journal 396(2), 201–14
Scheller, K., Scheller, C., Becker, S., Holzhausen, H.-J. and Schubert, J.
(2010). Cellular blue nevus (CBN) lymph node metastases of the neck with
no primary skin lesion: a case report and review of literature. Journal of
Cranio-Maxillo-Facial Surgery : Official Publication of the European
Association for Cranio-Maxillo-Facial Surgery 38(8), 601–4
Schuchter, L., Schultz, D. J., Synnestvedt, M., Trock, B. J., Guerry, D., Elder,
D. E., Elenitsas, R., Clark, W. H. and Halpern, A. C. (1996). A prognostic
model for predicting 10-year survival in patients with primary melanoma. The
Pigmented Lesion Group. Annals of Internal Medicine 125, 369–375
Scolyer, R. A., Murali, R., McCarthy, S. W. and Thompson, J. F. (2008).
Pathologic examination of sentinel lymph nodes from melanoma patients.
Seminars in Diagnostic Pathology 25(2), 100–11
Scolyer, R. A., Murali, R., McCarthy, S. W. and Thompson, J. F. (2010).
Histologically ambiguous (“borderline”) primary cutaneous melanocytic
tumors: approaches to patient management including the roles of molecular
testing and sentinel lymph node biopsy. Archives of Pathology & Laboratory
Medicine 134(12), 1770–7
Seegenschmiedt, M. H., Keilholz, L., Altendorf-Hofmann, A., Urban, A.,
Schell, H., Hohenberger, W. and Sauer, R. (1999). Palliative radiotherapy for
recurrent and metastatic malignant melanoma: prognostic factors for tumor
response and long-term outcome: a 20-year experience. International Journal
of Radiation Oncology biology physics 44(3), 607–618
Skelton, H. G., Smith, K. J., Barrett, T. L., Lupton, G. P. and Graham, J. H.
(1991). HMB-45 staining in benign and malignant melanocytic lesions. A
reflection of cellular activation. The American Journal of Dermatopathology
13, 543–550
Skender-Kalnenas, T. M., English, D. R. and Heenan, P. J. (1995). Benign
melanocytic lesions: risk markers or precursors of cutaneous melanoma?
Journal of the American Academy of Dermatology 33, 1000–1007